Tasmar

Active Ingredient(s): Tolcapone
FDA Approved: * January 29, 1998
Pharm Company: * VALEANT
Category: Parkinsons

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tasmar Overview

Tolcapone (brand name Tasmar) is a drug used to treat Parkinson's disease (PD). It is a selective, potent and reversible nitrocatechol-type inhibitor of the enzyme catechol-O-methyltransferase (COMT).[1] It has demonstrated significant liver toxicity, which has led to suspension of marketing authorisations in a number of countries. In comparison with entacapone, another nitrocatechol COMT inhibitor, tolcapone has a longer half life (2.9 hours vs. 0.8 hours) and can better pen...

Read more Tasmar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tolcapone

Recent Tasmar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Tasmar: (2 results)

Sorted by National Drug Code

• 0187-0938 Tasmar 100 mg Oral Tablet by Valeant Pharmaceuticals North America LLC
• 0187-0939 Tasmar 200 mg Oral Tablet by Valeant Pharmaceuticals North America LLC

Other drugs which contain Tolcapone or a similar ingredient: (1 result)

• TOLCAPONE